Clinical trials generate tons of data—everything from patient demographics to lab results and adverse events. This data often ...

The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...

MediciNova holds Orphan Drug Designation for MN-166 (ibudilast) in ALS by U.S. FDA and EU EMA. MN-166 (ibudilast) has received Fast Track Designation by FDA for treatment of ALS. In addition, MN-166 ...

A judge denied John Dougherty's motion to move his surrender date on Monday, which means the former Philadelphia labor leader will head to prison on Tuesday to begin his six-year sentence after he was ...

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on BridgeBio Pharma (BBIO – Research Report) today and set a price target ...

The Trials of a Time Lord provides a fun, if chaotic, rollercoaster through the heroes and villains of the Sixth Doctor era.

Generative AI is reshaping industries, and the legal community is facing pressing challenges, particularly concerning the ...

READING - The Killam School Building Committee will meet at 7 p.m. on Sept. 30. The meeting will be held at Town Hall and ...

In a report released yesterday, Justin Zelin from BTIG maintained a Buy rating on Poseida Therapeutics (PSTX – Research Report), with a ...

Fresenius Kabi, an operating company of Fresenius, specializing in biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs for critical and chronic conditions, and ...

Spiritual beliefs and a historically-based distrust of clinical research may factor into Black patients' decisions about whether to participate in cancer trials, according to surveys of patients ...

Kevin Meek litigates patent disputes in federal courts across the country, before the US International Trade Commission, and in post-grant ...